Inhibitory effect of banana (Musa sp. var. Nanjangud rasa bale) flower extract and its constituents Umbelliferone and Lupeol on α-glucosidase, aldose reductase and glycation at multiple stages

South African Journal of Botany

Volumn 95, Issue , 2014, Pages 54-63

  Ramu, Ramith ^a   Shirahatti, Prithvi S ^a   Zameer, Farhan ^b   Ranganatha, Lakshmi V ^c   Nagendra Prasad, M N ^a  

^a SRI JAYACHAMARAJENDRA COLLEGE OF ENGINEERING   (India)

^b Pooja Bhagavat Memorial Mahajana PG Centre   (India)

^c UNIVERSITY OF MYSORE   (India)

Author keywords

Aldose reductase; Diabetes mellitus; Ethanol extract; Glycation; Lupeol; Umbelliferone; Glucosidase inhibitors

Indexed keywords

DISEASE CONTROL; ENZYME ACTIVITY; ETHANOL; FRUIT; PROTEIN;

MUSA SP.;

EID: 84907494802     PISSN: 02546299     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sajb.2014.08.001     Document Type: Article

References (49)

1. Anthony D.M., Rex S., Clements Jr, Susan B.T., Frank O., Albert I.W. Glucose utilization by the polyol pathway in human erythrocytes. Biochemical and Biophysical Research Communications 1970, 40:199-205.
2. Aoife L., Richard O.K. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Current Pharmaceutical Design 2004, 10:3797-3811.
3. Aynilian G.H., Farnsworth N.R., Persinos G.J. Isolation of lupeol from Crataeva benthamii. Phytochemistry 1972, 11(9):2885-2886.
4. Bhaskar J.J., Salimath P.V., Nandini C.D. Stimulation of glucose uptake by Musa sp. (cv. elakki bale) flower and pseudostem extracts in Ehrlich ascites tumor cells. Journal of the Science of Food and Agriculture 2011, 91:1482-1487.
5. Casirola D.M., Ferraris R.P. Alpha-glucosidase inhibitors prevent diet induced increases in intestinal sugar transport in diabetic mice. Metabolism 2006, 55:832-841.
6. Casper G.S., Coen D.A.S., Victor W.M.V.H. Fructose-mediated non-enzymatic glycation: sweet coupling or bad modification. Diabetes Metabolism Research and Reviews 2004, 20(5):369-382.
7. Dhanabal S.P., Sureshkumar M., Ramanathan M., Suresh B. Hypoglycemic effect of ethanolic extract of Musa sapientum on alloxan induced diabetic mellitus in rats and its relation with antioxidant potential. Journal of Herbal Pharmacotherapy 2005, 5(2):7-19.
8. Dixon M. The determination of enzyme inhibitor constants. Biochemical Journal 1953, 55:170-171.
9. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959, 82:70-77.
10. Geetanjali K., Santosh S., Rakesh K.K., Naik S.N. Commonly consumed Indian plant food materials in the management of diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2010, 4(1):21-40.
11. Gonzalez R.G., Barnett P., Aguayo J., Cheng H.M., Chylack L.T. Direct measurement of polyol pathway activity in the ocular lens. Diabetes 1984, 33:196-199.
12. Harbone J.B. Phytochemical Methods 1973, 49-188. Chapman and Hall, Ltd., London.
13. International Diabetes Federation IDF Diabetes Atlas 2013, International Diabetes Federation, Brussels, Belgium. 6th edition.
14. Ivan A.R. Medicinal plants of the world-chemical constituents. Traditional Modern Medicinal Uses 2003, 155-163. Humana Press. N.J. Totawa (Ed.).
15. Ivo S. Glycation of albumin: reaction with glucose, fructose, galactose, ribose or glyceraldehyde measured using four methods. Journal of Biochemical and Biophysical Methods 1994, 28(2):115-121.
16. Johnson R.N., Metcalf P.A., Baker J.R. Fructosamine: a new approach to the estimation of serum glycosyl protein. An index of diabetic control. Clinica Chimica Acta 1983, 127:87-95.
17. Joshi S. Eugenia jambolana, Musa paradisiaca L. Medicinal Plants 2000, 286-294. Oxford and IBH Publishing Co. Pvt. Ltd, New Delhi. S. Joshi (Ed.).
18. Kador P.F., Robison W.G., Kinoshita J.H. The pharmacology of aldose reductase inhibitors. Annual Review of Pharmacology and Toxicology 1985, 25:691-714.
19. Kaur H., Perkins J. The free-radical chemistry of food additives. Free Radicals and Food Additives 1991, 17-35. Taylor and Francis, London. 0.I. Aruoma, B. Halliwell (Eds.).
20. Koji U., Masamichi K., Kensuke S., Tsukasa M. Protein-bound acrolein: potential markers for oxidative stress. Proceedings of the National Academy of Sciences of the USA (Biochemistry) 1998, 95:4882-4887.
21. Kwon Y.I., Apostolidis E., Kim Y.C., Shetty K. Health benefits of traditional corn, beans, and pumpkin: in vitro studies for hyperglycemia and hypertension management. Journal of Medicinal Food 2010, 10:266-275.
22. Lee D.S., Lee S.H. Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. FEBS Letters 2001, 501(1):84-86.
23. Lineweaver H., Burk D. The determination of enzyme dissociation constants. Journal of American Chemical Society 1934, 56:658-666.
24. Margareth B.C.G., Miranda J.S. Biological activities of lupeol. International Journal of Biomedical and Pharmaceutical Sciences 2009, 3(1):46-66.
25. McPherson J.D., Shilton B.H., Walton D.J. Role of fructose in glycation and cross-linking of proteins. Biochemistry 1988, 27:1901-1907.
26. Meghashri S., Vijay K.H., Gopal S. Antioxidant properties of a novel flavonoid from leaves of Leucas aspera. Food Chemistry 2010, 122:105-110.
27. Michael B. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
28. Mohammad Saleem Lupeol, a novel anti-inflammatory and anti-cancer dietary triterpene. Cancer Letters 2009, 285(2):109-115.
29. Molnar V., Garai J. Plant-derived anti-inflammatory compounds affect MIF tautomerase activity. International Immunopharmacology 2005, 5:849-856.
30. Nessar A. Advanced glycation endproducts - role in pathology of diabetic complications. Diabetes Research and Clinical Practice 2005, 67:3-21.
31. Nishimura C., Yamaoka T., Mizutani M., Yamashita K., Akera T., Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular Enzymology 1991, 1078:171-178.
32. Nurhanani R., Rasyidah R., Sarni M.J., Azlina A.A. Radical scavenging and reducing properties of extracts of cashew shoots (Anacardium occidentale). Food Chemistry 2008, 111:38-44.
33. Pari L., Maheswari J.U. Hypoglycaemic effect of Musa sapientum L. in alloxan-induced diabetic rats. Journal of Ethnopharmacology 1999, 68(1-3):321-325.
34. Paul J.T. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Archives of Biochemistry and Biophysics 2003, 419(1):31-40.
35. Peter F.K., Jin H.K., Norman E.S. Aldose reductase inhibitors: a potential new class of agents for the pharmacological control of certain diabetic complications. Journal of Medicinal Chemistry 1985, 28(7):841-849.
36. Prathapan A., Nampoothiri S.V., Mini S., Raghu K.G. Antioxidant, antiglycation and inhibitory potential of Saraca ashoka flowers against the enzymes linked to type 2 diabetes and LDL oxidation. European Review for Medical and Pharmacological Sciences 2012, 16:57-65.
37. Rajbir S., Bikram S., Sukhpreet S., Neeraj K., Subodh K., Saroj A. Umbelliferone-an antioxidant isolated from Acacia nilotica (L.) Willd. Ex. Del. Food Chemistry 2010, 120:825-830.
38. Ramith R., Prithvi S.S., Farhan Z., Nagendra M.N.P. Investigation of antihyperglycaemic activity of banana (Musa sp. var. Nanjangud rasa bale) pseudostem in normal and diabetic rats. Journal of the Science of Food and Agriculture 2014, 10.1002/jsfa.6698.
39. Revathi R., Manju V. Effects of umbelliferone on lipid peroxidation and antioxidant status in diethylnitrosamine-induced hepatocellular carcinoma. Journal of Acute Medicine 2013, 23:73-82.
40. Samuel R., James L.F. Novel inhibitors of advanced glycation endproducts. Archives of Biochemistry and Biophysics 2003, 419:63-79.
41. Shield J.P., Poyser K., Hunt L., Pennock C.A. Fructosamine and glycated haemoglobin in the assessment of long term glycaemic control in diabetes. Archives of Disease in Childhood 1994, 71(5):443-445.
42. Shuxia C., Xiaoqing S., Siqiong C., Panpan L., Junna D., Yanxia C., Huanwen M. Evaluation of garlic cultivars for polyphenolic content and antioxidant properties. PLoS ONE 2013, 8(11):e79730.
43. Singh R., Barden A., Mori T., Beilin L. Advanced glycation end-products: a review. Diabetologia 2001, 44(2):129-146.
44. Susanne H., Erich F.E. Transition metal ion-catalyzed oxygen activation during pathogenic processes. FEBS Letters 1999, 443:1-7.
45. Su-Yen G., Mark E.C. The role of advanced glycation end products in progression and complications of diabetes. The Journal of Clinical Endocrinology and Metabolism 2008, 93(4):1143-1152.
46. Wal P., Wal A., Sharma G., Rai A.K. Biological activities of lupeol. Systematic Reviews in Pharmacy 2011, 2:96-103.
47. Worawalai W., Wacharasindhu S., Phuwapraisirisan P. Synthesis of new N-substituted aminoquercitols from naturally available (+)-proto-quercitol and their α-glucosidase inhibitory activity. Medicinal Chemistry Communications 2012, 3:1466-1470.
48. Worthington V. Alpha amylase. Worthington Enzyme Manual 1993, 36-41. Worthington Biochemical Corp., Freehold, NJ. V. Worthington (Ed.).
49. Yen G.C., Duh P.D., Tsai H.L. Antioxidant and pro-oxidant properties of ascorbic acid and gallic acid. Food Chemistry 2002, 79:307-313.